(Q34476355)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Desiree Watson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Eduardo Castaño

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tyler A Kokjohn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Yuri Lyubchenko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

David Pinsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

E Sander Connolly

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Chera Esh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Dean C Luehrs

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

W Blaine Stine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Linda M Rowse

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Mark R Emmerling

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Alex E Roher

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

published in

Neurological Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

869-881

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Soluble amyloid Abeta-(1-40) exists as a stable dimer at low concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Normal and abnormal biology of the beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Clearing the brain's amyloid cobwebs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neprilysin regulates amyloid Beta peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Dityrosine Cross-Linked Aβ Peptides: Fibrillar β-Structure in Aβ(1-40) Is Conducive to Formation of Dityrosine Cross-Links but a Dityrosine Cross-Link in Aβ(8-14) Does Not Induce β-Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta-protein (A beta) associated with lipid molecules: immunoreactivity distinct from that of soluble A beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Gerstmann-Sträussler-Scheinker disease and the Indiana kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Variant Gerstmann-Sträussler syndrome with the P105L prion gene mutation: an unusual case with nigral degeneration and widespread neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Clinical significance of types of cerebellar amyloid plaques in human spongiform encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: molecular analysis of one case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Properties of neurotoxic peptides related to the BRI gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Oligomerizaiton and fibril asssembly of the amyloid-beta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Self-assembly of Abeta(1-42) into globular neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Theoretical models of the ion channel structure of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

The channel hypothesis of Alzheimer's disease: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Diversity of amyloid beta protein fragment [1-40]-formed channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neurodegenerative disease: amyloid pores from pathogenic mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

The other "closest living relative". How bonobos (Pan paniscus) challenge traditional assumptions about females, dominance, intra- and intersexual interactions, and hominid evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Statins inhibit A beta-neurotoxicity in vitro and A beta-induced vasoconstriction and inflammation in rat aortae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Inhibition of angiogenesis by Abeta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: roles of endoplamic reticulum-bound p97/Cdc48p and proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Protein unfolding by mitochondria. The Hsp70 import motor

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH2 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neurogenic effect of beta-amyloid peptide in the development of neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Amyloid beta vaccination: reduced plaques and improved cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X49436

21 January 2018

Identifiers

DOI

10.1179/016164105X49436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16354549%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference